Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States
2 institutional releases
Published in New England Journal of Medicine · View the paper (DOI)
A study led by Harvard T.H. Chan School of Public Health researchers found that dolutegravir-based regimens are more effective in treating HIV-1 during pregnancy than other commonly used ART regimens. The study showed high viral suppression rates for pregnant people taking dolutegravir, with no observed differences in adverse birth out...